ebomi
Colour theme
Sign in
Insider · CIK 0001569248

Burow Kristina

CIK 0001569248 Name as filed on the most recent filing

Filed as Burow Kristina (27)

59 transaction lines · from 27 filings · filed 2013-05-14 to 2026-07-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

47 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-07-01 S, Open-market sale Boundless Bio, Inc.BOLD 39,840, disposed Open Form 4 filing 0001012975-26-000622
2026-07-01 S, Open-market sale Scholar Rock Holding CorpSRRK 2 lines 164,064, disposed Open Form 4 filing 0001193125-26-296248
2026-06-22 P, Open-market purchase Kardigan, Inc.KARD 20,000,000, acquired Open Form 4 filing 0001012975-26-000564
2026-05-04 P, Open-market purchase Seaport Therapeutics, Inc.SPTX 19,800,000, acquired Open Form 4 filing 0001193125-26-204458
2026-03-06 P, Open-market purchase Lyell Immunopharma, Inc.LYEL 12,499,985, acquired Open Form 4 filing 0001012975-26-000234
2025-10-27 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 4,999,977, acquired Open Form 4 filing 0001012975-25-000681
2025-08-01 P, Open-market purchase Prime Medicine, Inc.PRME 9,999,990, acquired Open Form 4 filing 0001062993-25-013460
2025-05-29 S, Open-market sale Scholar Rock Holding CorpSRRK 2 lines 160,511, disposed Open Form 4 filing 0001415889-25-015005
2025-02-03 P, Open-market purchase Metsera, Inc.MTSR 2 lines 39,999,996, acquired Open Form 4 filing 0000950170-25-012590
2024-04-02 P, Open-market purchase Boundless Bio, Inc.BOLD 2 lines 3,200,000, acquired Open Form 4 filing 0000950170-24-041844
2024-02-15 P, Open-market purchase Prime Medicine, Inc.PRME 20,000,000, acquired Open Form 4 filing 0001062993-24-003738
2024-02-08 P, Open-market purchase Sana Biotechnology, Inc.SANA 3 lines 9,999,996, acquired Open Form 4 filing 0001062993-24-002841
2023-11-14 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 40,217, acquired Open Form 4 filing 0001062993-23-020934
2023-11-13 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 371,923, acquired Open Form 4 filing 0001062993-23-020934
2023-11-10 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 2 lines 198,481, acquired Open Form 4 filing 0001062993-23-020714
2023-11-09 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 327,262, acquired Open Form 4 filing 0001062993-23-020714
2023-11-08 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 2 lines 1,017,821, acquired Open Form 4 filing 0001062993-23-020714
2023-11-07 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 347,208, acquired Open Form 4 filing 0001062993-23-020280
2023-11-06 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 497,597, acquired Open Form 4 filing 0001062993-23-020280
2023-11-03 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 255,140, acquired Open Form 4 filing 0001062993-23-020280
2023-09-29 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 483,149, acquired Open Form 4 filing 0001062993-23-018633
2023-09-28 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 2 lines 563,699, acquired Open Form 4 filing 0001062993-23-018633
2023-09-27 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 301,644, acquired Open Form 4 filing 0001062993-23-018548
2023-09-26 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 398,820, acquired Open Form 4 filing 0001062993-23-018548
2023-09-25 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 2 lines 681,464, acquired Open Form 4 filing 0001062993-23-018468
2023-09-22 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 445,600, acquired Open Form 4 filing 0001062993-23-018468
2023-09-19 P, Open-market purchase Neumora Therapeutics, Inc.NMRA 25,500,000, acquired Open Form 4 filing 0001610717-23-000291
2022-10-24 P, Open-market purchase Prime Medicine, Inc.PRME 2 lines 13,600,000, acquired Open Form 4 filing 0001628280-22-027125
2021-07-30 P, Open-market purchase Da32 Life Science Tech Acquisition Corp.DALS 16,000,000, acquired Open Form 4 filing 0000899243-21-031417
2020-09-18 P, Open-market purchase Metacrine, Inc.MTCR 2 lines 2,990,000, acquired Open Form 4 filing 0001209191-20-051403
2019-10-16 P, Open-market purchase Vir Biotechnology, Inc.VIR 20,000,000, acquired Open Form 4 filing 0001209191-19-053666
2019-02-22 P, Open-market purchase Sienna Biopharmaceuticals, Inc.SNNA 3 lines 5,414,500, acquired Open Form 4 filing 0001012975-19-000197
2014-05-29 S, Open-market sale Receptos, Inc.RCPT 2 lines 834,335, disposed Open Form 4 filing 0001012975-14-000340
2014-05-28 S, Open-market sale Receptos, Inc.RCPT 2 lines 1,979,293, disposed Open Form 4 filing 0001012975-14-000340

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 31
  • Open-market sale 16
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Burow Kristina, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001569248

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.